|

SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery

RECRUITINGN/ASponsored by Adichunchanagiri Institute of Medical Sciences, B G Nagara
Actively Recruiting
PhaseN/A
SponsorAdichunchanagiri Institute of Medical Sciences, B G Nagara
Started2025-10-20
Est. completion2026-02
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07241091

Summary

This dual-centre, randomized controlled trial evaluates the safety and efficacy of high-purity Type-I collagen-based biomaterial, as a peritoneal substitute following peritonectomy in patients undergoing cytoreductive surgery (CRS) for peritoneal surface malignancy. The study tests whether Surgicoll-Mesh can reduce major postoperative intra-abdominal complications compared with standard management.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age ≥18 years
* Diagnosed peritoneal surface malignancy (colorectal, ovarian, appendiceal, mesothelioma, pseudomyxoma)
* Undergoing cytoreductive surgery ± HIPEC requiring peritonectomy
* ECOG 0-2, adequate organ function, informed consent

Exclusion Criteria:

* Collagen allergy or active infection
* Immunosuppression or chronic steroid use
* Pregnancy/lactation
* Uncontrolled sepsis, bowel perforation, or extensive small bowel resection

Conditions7

Bowel ObstructionCancerOvarian Cancer (OvCa)Peritoneal Surface MalignancyPostoperative AdhesionSurgical Site Infection After Major SurgeryWound Complications

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.